Posted on

cbd oil stocks canada

Here’s why Jushi Holdings is a much better stock for the long-term investor compared to Canopy Growth right now. Read More »

Here’s how I would explain HEXO stock’s 27.8% plunge on Friday: desperation, bad timing, and an overreaction. Read More »

Forget Canopy Growth and Buy This Pot Stock Instead

Here’s why Green Thumb Industries is a much better long-term bet compared to Aurora Cannabis. Read More »

Canopy Growth Corp.’s (TSX:WEED)(NYSE:CGC) international medical business operates primarily as a pharmacy model, with pharmacies being deemed essential businesses in Germany and other European. Read More »

Investors considering Canopy Growth (TSX:WEED)(NYSE:CGC) stock have a lot to consider as we enter Q3. Read More »

Namaste Technologies Inc. (OTC: NXTTF) focuses on the e-commerce side of the medical marijuana business. The company operates 32 sites in 20 different countries. In 2017, Namaste added CannMart into its portfolio, which has a distribution network in Toronto. This helps the site develop its retail distribution.   The stock has declined by 38.7% year-to-date.

This is a stark contrast to what’s happening up north. Canada legalized medical marijuana in 2001, leading to a greater evolution of the industry in the country.   Consider how the laws have been changing in the Great White North. Canada’s House of Commons passed the Cannabis Act (Bill C-45) in November 2017 to legalize the recreational use of marijuana. And in June 2018, it received the Royal Assent (formal approval of an act by a monarch).  

Market Cap: $1.621B

8. OrganiGram Holdings

Mrinalini Krishna is an expert on alternative investments as well as company and market news. With over 10 years of business journalism experience, Mrinalini has written stories about business, finance, and the marijuana industry. She received her Bachelor of Arts with honors in economics from the University of Delhi, her Master of Arts in mass communication from the Symbiosis Institute of Media and Communication, and her Master of Arts in business and economic reporting from New York University.

Market Cap: $39.445M

HEXO (HEXO) is the first licensed medical marijuana producer headquartered in Quebec. This company focuses on recreational marijuana use. In October 2019, HEXO launched Original Stash, a value-conscious line of cannabis priced at just $4.49 per ounce, including taxes. HEXO stock has dropped by more than 45% year-to-date.

OrganiGram Holdings (OGI) is a licensed producer of medical marijuana products. It began trading on the Nasdaq in May of 2019. This company’s portfolio includes dry cannabis and cannabis oil, along with accessories like vaporizers that can be purchased on its website. OrganiGram’s share price has declined by about 29% year-to-date.

While much of GrowGeneration’s business caters to cannabis growers, the company also sells to other types of gardeners. GrowGeneration has benefitted from the COVID-19 pandemic due to the surge in customers pursuing organic gardening at home.

The COVID-19 pandemic disrupted IIP’s business somewhat, with three tenants receiving temporary rent deferrals. The ancillary company has still grown phenomenally during the pandemic and is highly profitable. Because the company is organized as a real estate investment trust (REIT), IIP returns at least 90% of its taxable income to shareholders.

4. GrowGeneration

With the legal recreational marijuana market in Illinois opening for business at the beginning of 2020, this company is benefiting from tremendous growth in its home state. Along with the opportunity to expand into additional states such as New York and New Jersey, the company has significant growth potential.

The Motley Fool

The COVID-19 pandemic has affected nearly every part of the global economy, including the cannabis industry. In many U.S. states, cannabis dispensaries were designated as essential businesses. Cannabis sales boomed in some states during the first few months of the coronavirus outbreak, driven in part by more time spent at home and increased anxiety. Marijuana growers and retailers benefited, as did ancillary providers selling gardening supplies and other products to these companies.